Interleukin-10-based therapy for inflammatory bowel disease

Author： Braat Henri Peppelenbosch Maikel P Hommes Daan W

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.3, Iss.5, 2003-08, pp. : 725-731

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Alicaforsen therapy in inflammatory bowel disease

By Barish Charles F

Expert Opinion on Biological Therapy, Vol. 5, Iss. 10, 2005-10 ,pp. : 1387-1391

Informa Healthcare

Access to resources Recommend Favorite

Association between polymorphisms in the promoter region of interleukin-10 and susceptibility to inflammatory bowel disease

By Lv Hongchao Jiang Yongshuai Li Jin Zhang Mingming Shang Zhenwei Zheng Jiajia Wu Xin Liu Panpan Zhang Ruijie Yu Huimin

Molecular Biology Reports, Vol. 41, Iss. 3, 2014-03 ,pp. : 1299-1310

Springer Publishing Company

Access to resources Recommend Favorite

Interleukin-1 receptor antagonist as therapy for inflammatory disorders

By Freeman B.D. Buchman T.G.

Expert Opinion on Biological Therapy, Vol. 1, Iss. 2, 2001-03 ,pp. : 301-308

Informa Healthcare

Access to resources Recommend Favorite

Depleted mucosal antioxidant defences in inflammatory bowel disease

By Buffinton G.D. Doe W.F.

Free Radical Biology and Medicine, Vol. 19, Iss. 6, 1995-12 ,pp. : 911-918

Elsevier

Access to resources Recommend Favorite

Adrenomedullin as a Potential Therapeutic Agent for Inflammatory Bowel Disease

Current Protein and Peptide Science, Vol. 14, Iss. 4, 2013-06 ,pp. : 246-255

Bentham Science Publishers

Access to resources Recommend Favorite